Drug Trial Radar · NCT06109415
Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)
Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Oct 20, 2021
Primary completion
Jul 18, 2022
Study completion Jul 29, 2022
Sponsor
- Lead sponsor
- Heron TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 31, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Cohort 1 (subjects undergoing total shoulder arthroplasty, TSA) of a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing different surgical procedures. See also the separate record for the master study protocol (NCT05109312).
Conditions
- Postoperative Pain
- Total Shoulder Arthroplasty
- Multimodal Analgesia
Interventions
HTX-011Drug
HTX-011 (bupivacaine/meloxicam) extended-release solution for instillation use, supplied in commercially available ZYNRELEF kits
Bupivacaine HydrochlorideDrug
bupivacaine HCl (without epinephrine) 0.25%
MMA regimenDrug
acetaminophen 1 g q8h every 8 hours (q8h) and ibuprofen 400 mg q8h, alternating the 2 medications so that an analgesic was taken approximately every 4 hours (q4h)
ZYNRELEF kit components for administrationDevice
ZYNRELEF kits include sterile, individually packaged components for administration, including vented vial spikes, Luer lock syringes, custom Luer lock applicators, and syringe tip caps.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of TEAEsTime frame: Through Day 15
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Woodland International Research Group, LLC
Little Rock, Arkansas
Center for Orthopaedic Reconstruction and Excellence
Jenks, Oklahoma
First Surgical Hospital
Bellaire, Texas
Legent Orthopedic Hospital
Carrollton, Texas
JBR Clinical Research
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.